Evidence map›Paper›PMID 27148226›Full record

ArticleFrontiers in microbiology2016

Identification and Characterization of a Cleavage Site in the Proteolysis of Orf Virus 086 Protein.

Xiaoping Wang, Bin Xiao, Jiafeng Zhang, Daxiang Chen, Wei Li, Ming Li, Wenbo Hao, Shuhong Luo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiaoping WangInstitute of Antibody Engineering, School of Biotechnology, Southern Medical UniversityGuangzhou, China; Department of Laboratory, Medicine Nongken Centre, Hospital of GuangdongZhanjiang, China.
Bin XiaoInstitute of Antibody Engineering, School of Biotechnology, Southern Medical UniversityGuangzhou, China; Department of Laboratory Medicine, Guangzhou General Hospital of Guangzhou Military CommandGuangzhou, China.
Jiafeng ZhangInstitute of Antibody Engineering, School of Biotechnology, Southern Medical University Guangzhou, China.
Daxiang ChenInstitute of Antibody Engineering, School of Biotechnology, Southern Medical University Guangzhou, China.
Wei LiInstitute of Antibody Engineering, School of Biotechnology, Southern Medical University Guangzhou, China.
Ming LiInstitute of Antibody Engineering, School of Biotechnology, Southern Medical UniversityGuangzhou, China; Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Epidemiology, School of Public Health, Southern Medical UniversityGuangzhou, China; State Key Laboratory of Organ Failure, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Biotechnology, Southern Medical UniversityGuangzhou, China.
Wenbo HaoInstitute of Antibody Engineering, School of Biotechnology, Southern Medical UniversityGuangzhou, China; Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Epidemiology, School of Public Health, Southern Medical UniversityGuangzhou, China.
Shuhong LuoInstitute of Antibody Engineering, School of Biotechnology, Southern Medical UniversityGuangzhou, China; Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Epidemiology, School of Public Health, Southern Medical UniversityGuangzhou, China.
Southern Medical University · CNCentral People's Hospital of Zhanjiang · CNGeneral Hospital of Guangzhou Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The orf virus (ORFV) is among the parapoxvirus genus of the poxviridae family, but little is known about the proteolytic pathways of ORFV encoding proteins. By contrast, the proteolysis mechanism of the vaccinia virus (VV) has been extensively explored. Vaccinia virus core protein P4a undergoes a proteolytic process that takes place at a conserved cleavage site Ala-Gly-X (where X is any amino acid) and participates in virus assembly. Bioinformatics analysis revealed that an ORFV encoding protein, ORFV086, has a similar structure to the vaccinia virus P4a core protein. In this study, we focus on the kinetic analysis and proteolysis mechanism of ORFV086. We found, via kinetic analysis, that ORFV086 is a late gene that starts to express at 8 h post infection at mRNA level and 12-24 h post infection at the protein level. The ORFV086 precursor and a 21 kDa fragment can be observed in mature ORFV virions. The same bands were detected at only 3 h post infection, suggesting that both the ORFV086 precursor and the 21 kDa fragment are viral structural proteins. ORFV086 was cleaved from 12 to 24 h post infection. The cleavage took place at different sites, resulting in seven bands with differing molecular weights. Sequence alignment revealed that five putative cleavage sites were predicted at C-terminal and internal regions of ORFV086. To investigate whether those cleavage sites are involved in proteolytic processing, full length and several deletion mutant ORFV086 recombinant proteins were expressed and probed. The GGS site that produced a 21 kDa cleavage fragment was confirmed by identification of N/C-terminal FLAG epitope recombinant proteins, site-directed mutagenesis and pulse-chase analysis. Interestingly, chase results demonstrated that, at late times, ORFV086 is partially cleaved. Taken together, we concluded that GGS is a cleavage site in ORFV086 and produces a 21 kDa fragment post infection. Both ORFV086 precursor and the 21 kDa fragment are structural proteins of mature ORFV virions. ORFV086 and its cleaved products are indispensable for correct assembly of mature viral particles and this proteolytic processing of ORFV086 may play an essential role in viral morphogenic transition.

Indexed as

ORFV086orf virusproteolysispulse-chase

Identifiers

PMID27148226
PMCPMC4837287
OpenAlexW2336175581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.